Select Page

Company to buy

  • Size: Small
  • Sales: < 15 million EUR
  • Location: Western Europe
  • Reason for acquisition: The management wants to expand their business
  • #CFIE PHB190

Overview of buyer for oncology CRO in Western Europe

A contract research organization (CRO) focused on oncological research is looking for suitable oncological CRO targets for acquisition. The company operates in Western Europe.

Profile (strategy) of buyer for oncology CRO in Western Europe

The company’s strategy is centered around being a data-focused CRO. This enables the company to increase its agility. High-powered analytical tools and data visualization expertise allows the company to peruse and analyze clinical trials with above-average accuracy and critical efficiency. This leads to quick and impactful insights that anticipate risks involved in the trial process. Risk impact analysis is a company differential. Most importantly, the management is highly attentive to tech advancements and applications.
The company has reached a milestone of having over 200 personnel. The highly qualified staff specializes in all therapeutic areas. The focus is on innovative oncological therapies and on being an early-phase hub. Above all, the company has over 20 years of valuable experience in oncology, especially in early-phase studies, data-driven studies, and pharmacovigilance.

Subscribe as an interested seller
Contact us to get details about this buyer for oncology CRO in Western Europe

Activities and products of a suitable target

The target company profile is a contract research organization (CRO) with significant experience and a track record in oncology. The target should operate in Western Europe. The ideal annual revenue range is up to 15 million euros. It should be noted that experience with early-phase studies, data studies, and pharmacovigilance is highly desirable.

Highlights

  • Western European CRO focused on oncology, early-phase and data-driven studies, and pharmacovigilance
  • High-quality clinical research services provided, with a proven track record of more than 20 years
  • A customer-centric approach focused on building long-term relationships, trust, and confidence
  • Talented, excited, and diverse staff passionate about clinical research and the company

More information on this buyer for oncology CRO in Western Europe

Please get in touch if you are interested in learning more about this buyer for oncology CRO in Western Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this CRO buyer

en_GBEnglish (UK)